Galleri wins FDA panel nod as GRAIL chases first multi-cancer screening approval
GRAIL's Galleri blood test just cleared a key FDA advisory vote, putting it on track to become the first FDA-approved multi-cancer screening tool, with a final decision expected in early 2027. The company ran more than 174,000 tests in nine months of 2026 and posted a 24% volume jump in Q3, even as it trades near-term margin for market share.
- Original source: pluang.com.
- The source published it on Nov 19, 2026 at 5:53 AM.
- No second outlet has reported it yet. Treat it as a single-source claim.
GRAIL's Galleri multi-cancer early detection test cleared a positive vote from an FDA advisory panel, lining it up to become the first multi-cancer screening tool with full FDA approval. A final decision is expected in early 2027. In the meantime, the company says it completed more than 174,000 Galleri tests across the first nine months of 2026, with test volume climbing 24% in the third quarter alone.
GRAIL is chasing reach before profit. It is leaning on promotional pricing to pull in more customers and prioritizing market expansion over short-term margins, with a target of 50-60% gross margins once scale brings costs down. The company is sitting on $788.7 million in cash, which it says will fund both that growth push and its efforts to win insurance coverage through 2029.
Health-sector stocks on Pluang's US list were mixed on Nov 19, 2026, with 69 of 150 names gaining and 76 declining. Among the movers: ALMS sat at USD 4.39, down 9.30%, while BFLY rose 8.87% to USD 6.26 and SYRE climbed 8.30% to USD 101.60. Typical hold times on those names run between 6 and 23 days.
TopicsGRAIL · Galleri · FDA · Pluang · ALMS · BFLY · SYRE
Source: pluang.com
Written by AI from verified reporting.
More stories
- Health & science techtimes.com 2 sources 2 viewsFDA Clears Regeneron's Quarterly RNA Shot Livsayis for Myasthenia Gravis
- Health & science reuters.com Caught by @Coen 2 viewsFDA stands up internal council to vet vaccines and gene therapies after approval
- Health & science medicalxpress.com Caught by @boxlink 4 viewsThe brain builds a word blueprint a quarter-second before you speak, UCSF finds
- Health & science adelaide.edu.au Caught by @boxlink 2 viewsAdelaide quantum team ditches hundreds of loops, keeps sensor sensitivity

